{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:09:54Z","timestamp":1771049394174,"version":"3.50.1"},"reference-count":27,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T00:00:00Z","timestamp":1582761600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2020.00132","type":"journal-article","created":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T05:13:42Z","timestamp":1582780422000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":28,"title":["Meta-Analysis of Paclitaxel-Based Chemotherapy Combined With Traditional Chinese Medicines for Gastric Cancer Treatment"],"prefix":"10.3389","volume":"11","author":[{"given":"Yicong","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinbing","family":"Sui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeqi","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunyue","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoguang","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia L.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuhao","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kexin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Ding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1093\/jjco\/hyf057","article-title":"Docetaxel 75 mg\/m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial","volume":"32","author":"Bang","year":"2002","journal-title":"Jpn J. Clin. Oncol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/S1470-2045(17)30682-4","article-title":"Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"18","author":"Bang","year":"2017","journal-title":"Lancet Oncol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1007\/s10555-019-09803-7","article-title":"Update on gastric cancer treatments and gene therapies","volume":"38","author":"Biagioni","year":"2019","journal-title":"Cancer Metastasis Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"B5","doi-asserted-by":"publisher","first-page":"CD004520","DOI":"10.1002\/14651858.CD004520.pub7.Cd004520","article-title":"Chinese herbal medicine for oesophageal cancer","volume":"1","author":"Chen","year":"2016","journal-title":"Cochrane Database Syst. Rev."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4924279","DOI":"10.1155\/2018\/4924279","article-title":"Jianpi Bushen, a traditional chinese medicine therapy, combined with chemotherapy for gastric cancer treatment: a meta-analysis of randomized controlled trials","volume":"2018","author":"Chen","year":"2018","journal-title":"Evid. Based Complement Alternat. Med."},{"key":"B7","doi-asserted-by":"publisher","first-page":"0035","DOI":"10.3969\/j.issn.1004-745X.2009.01.020","article-title":"Effect of Huachansu combined with TPF in the treatment of advanced gastric cancer","volume":"18","author":"Chen","year":"2009","journal-title":"J. Emergency Tradi. Chin. Med."},{"key":"B8","first-page":"0093","article-title":"Clinical observation of Jianpixiaozheng Decoction combined with chemotherapy in the treatment of advanced gastric cancer","volume":"32","author":"Ge","year":"2014","journal-title":"J. Sichuan Tradi. Chin. Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"B10","doi-asserted-by":"publisher","first-page":"0200","DOI":"10.13194\/j.issn.1673-842x.2018.10.053","article-title":"Clinical observation of Jianpi Yiqi method combined with TP chemotherapy in treating advanced gastric cancer","volume":"20","author":"Huang","year":"2018","journal-title":"J. Liaoning Univ. TCM"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin. Trials"},{"key":"B12","doi-asserted-by":"publisher","first-page":"0018","DOI":"10.13260\/j.cnki.jfjtcm.011725","article-title":"Effect of Shenlingbaizhu Decoction on the immunosuppressive state of gastric cancer treated with dose intensive chemotherapy","volume":"49","author":"Lai","year":"2018","journal-title":"Fujian J. TCM"},{"key":"B13","doi-asserted-by":"publisher","first-page":"0154","DOI":"10.16294\/j.cnki.1007-659x.2010.02.039","article-title":"Liujunzi Decoction combined with chemotherapy in the treatment of advanced gastric cancer","volume":"34","author":"Li","year":"2010","journal-title":"J. Shandong Univ. TCM"},{"key":"B14","doi-asserted-by":"publisher","first-page":"0122","DOI":"10.3969\/j.issn.1006-3765.2016.01.059","article-title":"Clinical effect of Rg3 combined with paclitaxel in the treatment of liver metastasis after gastric cancer operation","volume":"28","author":"Li","year":"2016","journal-title":"Strait Phar. J."},{"key":"B15","doi-asserted-by":"publisher","first-page":"0138","DOI":"10.13194\/j.issn.1673-842x.2016.11.042","article-title":"Observation of Paclitaxel liposome Fufang Kushen injection and Yiqi Yangwei decoction combined with in the treatment of advanced gastric cancer with malignant ascites","volume":"18","author":"Li","year":"2016","journal-title":"J. Liaoning Univ. TCM"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.13288\/j.11-2166\/r.2016.16.012","article-title":"Clinical observation on 50 cases of advanced gastric cancer treated with Shenlingbaizhu decoction combined with TS chemotherapy","volume":"57","author":"Li","year":"2016","journal-title":"J. Tradi. Chin. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"0033","DOI":"10.3969\/j.issn.2096-3327.2018.07.011","article-title":"Investigation on short-term efficacy and safety of Docetaxel and Cisplatin combined with Kang'ai injection in the treatment of advanced gastric cancer","volume":"15","author":"Liao","year":"2018","journal-title":"Chin. J. Ration. Drug Use"},{"key":"B18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3969\/j.issn.1673-9701.2009.29.007","article-title":"Clinical efficacy of Aidi injection combined with TPF in the treatment of advanced gastric carcinoma","volume":"47","author":"Liu","year":"2009","journal-title":"China Mod. Doct."},{"key":"B19","doi-asserted-by":"publisher","first-page":"0139","DOI":"10.14164\/j.cnki.cn11-5581\/r.2019.09.081","article-title":"Paclitaxel liposome combined with Fufangkushen injection and Yiqiyangwei Decoction in the treatment of advanced gastric cancer with malignant ascites","volume":"13","author":"Meng","year":"2019","journal-title":"Clin. J. Mod. Drug Appl."},{"key":"B20","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.1093\/annonc\/mdq248","article-title":"Neutropenia as a prognostic factor in advanced gastric cancer patients undergoing second-line chemotherapy with weekly paclitaxel","volume":"21","author":"Shitara","year":"2010","journal-title":"Ann. Oncol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"0393","DOI":"10.3969\/j.issn.1671-8348.2013.04.012","article-title":"Efficacy of Fufangbanmao capsules combined chemotherapy in the treatment of advanced gastric cancer in gerontal patients","volume":"4","author":"Tan","year":"2013","journal-title":"Chongqing Med."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004064.pub4","article-title":"Chemotherapy for advanced gastric cancer","volume":"8","author":"Wagner","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"key":"B23","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1053\/ctrv.2001.0227","article-title":"Integration of Chinese medicine into supportive cancer care: a modern role for an ancient tradition","volume":"27","author":"Wong","year":"2001","journal-title":"Cancer Treat Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.mehy.2013.04.038","article-title":"Efficacy and safety of Huachansu combined with chemotherapy in advanced gastric cancer: a meta-analysis","volume":"81","author":"Xie","year":"2013","journal-title":"Med. Hypotheses"},{"key":"B25","first-page":"4577","article-title":"Clinical effect of Rg3 combined with paclitaxel in the treatment of liver metastasis after gastric cancer operation","volume":"28","author":"Xue","year":"2017","journal-title":"Mod. Diagn. Treat"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.3969\/j.issn.1000-7369.2009.09.004","article-title":"The effect of Fuzhenghewei liquid medicament on the quality of life in the treatment of advanced gastric cancer","volume":"9","author":"You","year":"2009","journal-title":"Shaanxi J. Tradi. Chin. Med."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2019.00717","article-title":"A Bayesian network meta-analysis for identifying the optimal taxane-based chemotherapy regimens for treating gastric cancer","volume":"10","author":"Zhang","year":"2019","journal-title":"Front. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00132\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,27]],"date-time":"2020-02-27T05:13:50Z","timestamp":1582780430000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2020.00132\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,27]]},"references-count":27,"alternative-id":["10.3389\/fphar.2020.00132"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2020.00132","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,27]]},"article-number":"132"}}